Summary
Updated Aug 30, 2026
Robert Graham Susman is Director of Immunovant, Inc. (IMVT). 2 SEC Form 4 filings on record, most recently on 1 May 2026. Most recent open-market trade: sold $68K of IMVT on 1 May 2026. Lifetime open-market sales: $68K.
Recent Transactions
2Every recent SEC Form 4 transaction Robert Graham Susman has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Robert Graham Susman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Andrew J. Fromkin - $7.96M of IMVT open-market activity in the last 12 months
- Jay S. Stout - $2.24M of IMVT open-market activity in the last 12 months
- Melanie Gloria - $1.60M of IMVT open-market activity in the last 12 months
- Tiago Girao - $1.41M of IMVT open-market activity in the last 12 months
- Tuyl Christopher van - $1.02M of IMVT open-market activity in the last 12 months
- Eric Venker - $462K of IMVT open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Robert Graham Susman?
Robert Graham Susman is a corporate insider, tracked as Director of Immunovant, Inc. (IMVT). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Robert Graham Susman last file a Form 4?
The most recent primary Form 4 on record is dated 1 May 2026, one of 2 filings going back to 2026.
Has Robert Graham Susman been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($68K) across all tracked filings.
Where can I see all of Robert Graham Susman's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Robert Graham Susman and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
